Skip to main content
    M

    MoonLake Immunotherapeutics (MLTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $11.73
    -0.77 (-6.16%)

    Market Cap: $1.06B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    MoonLake Immunotherapeutics (MLTX) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    MoonLake Immunotherapeutics (MLTX) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, MoonLake Immunotherapeutics reported EPS of -$0.93, below the -$0.77 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    47%(9/19)
    Avg Surprise
    -0.13%

    Upcoming Estimates

    Reports Feb 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.84
    Range-$0.99 - -$0.69
    15 analysts
    Revenue Consensus
    N/A
    RangeN/A
    14 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.94
    Range-$1.18 - -$0.79
    3 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.87-7.3%
    60d ago-$1.03+8.6%
    30d ago-$1.03+8.6%
    7d ago-$1.03+8.6%
    Current-$0.94
    Revenue Consensus
    $74.75K
    RangeN/A
    8 analysts

    Next Report

    MLTX has an expected report date of Feb 22, 2027.

    Earnings History

    Of the 19 quarters below that had an estimate, MLTX beat 9, missed 9 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2022, when EPS landed 53.57% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.93-$0.77-$0.88 - -$0.66-20.78%MissN/A76 up, 0 downNov 4, 2026
    Jun 30, 2026-$0.84-$0.90-$1.02 - -$0.75+6.67%BeatN/A82 up, 1 downAug 10, 2026
    Mar 31, 2026-$0.98-$0.92-$1.01 - -$0.81-6.52%MissN/A82 up, 0 downMay 11, 2026
    Dec 31, 2025-$0.92-$0.98-$1.03 - -$0.88+6.05%BeatN/A81 up, 0 downFeb 25, 2026
    Sep 30, 2025-$1.10-$0.89-$0.99 - -$0.84-23.60%MissN/A70 up, 3 downNov 5, 2025
    Jun 30, 2025-$0.87-$0.76-$0.83 - -$0.70-14.47%MissN/A74 up, 0 downAug 5, 2025
    Mar 31, 2025-$0.63-$0.74-$0.85 - -$0.54+14.34%BeatN/A90 up, 2 downMay 12, 2025
    Dec 31, 2024-$0.72-$0.59-$0.76 - -$0.39-22.03%MissN/A90 up, 1 downFeb 26, 2025
    Sep 30, 2024-$0.56-$0.45-$0.53 - -$0.33-24.44%MissN/A150 up, 1 downNov 7, 2024
    Jun 30, 2024-$0.39-$0.28-$0.38 - -$0.22-39.29%MissN/A130 up, 0 downAug 7, 2024
    Mar 31, 2024-$0.22-$0.21-$0.30 - -$0.11-4.76%MissN/A110 up, 0 downMay 7, 2024
    Dec 31, 2023-$0.12-$0.23-$0.37 - -$0.15+47.83%BeatN/A131 up, 0 downFeb 29, 2024
    Sep 30, 2023-$0.18-$0.25-$0.30 - -$0.13+28.00%BeatN/A120 up, 0 downNov 14, 2023
    Jun 30, 2023-$0.23-$0.29-$0.37 - -$0.21+20.69%BeatN/A100 up, 0 downAug 10, 2023
    Mar 31, 2023-$0.23-$0.31-$0.44 - -$0.19+25.81%BeatN/A83 up, 0 downMay 11, 2023
    Dec 31, 2022-$0.43-$0.28-$0.38 - -$0.28-53.57%MissN/A70 up, 0 downMar 20, 2023
    Sep 30, 2022-$0.27-$0.34-$0.37 - -$0.29+20.59%BeatN/A30 up, 0 downNov 14, 2022
    Jun 30, 2022-$0.34-$0.54N/A+37.04%BeatN/A21 up, 1 downAug 12, 2022
    Mar 31, 2022-$0.35-$0.35N/A0.00%In lineN/AN/AN/AMay 16, 2022
    Dec 31, 2021-$0.15N/AN/AN/AN/AN/AN/AN/AFeb 17, 2022
    Sep 30, 2021-$0.14N/AN/AN/AN/AN/AN/AN/ANov 12, 2021
    Jun 30, 2021-$0.01N/AN/AN/AN/AN/AN/AN/AAug 16, 2021
    Mar 31, 2021-$0.01N/AN/AN/AN/AN/AN/AN/AMay 21, 2021
    Dec 31, 2020-$0.01N/AN/AN/AN/AN/AN/AN/AMar 31, 2021
    Sep 30, 2020Not reportedN/AN/AN/ANot reportedN/AN/AN/ADec 3, 2020
    Last 25 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$3.52, after -$1.89 the year before. It was -$0.01 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$3.52N/A
    Dec 31, 2024-$1.89N/A
    Dec 31, 2023-$0.76N/A
    Dec 31, 2022-$1.39N/A
    Dec 31, 2021-$0.31N/A
    Dec 31, 2020-$0.01N/A

    Frequently Asked Questions About MLTX

    When is MoonLake Immunotherapeutics's next earnings date?

    MoonLake Immunotherapeutics's next earnings report is expected for Feb 22, 2027.

    Did MLTX beat earnings estimates last quarter?

    No. MoonLake Immunotherapeutics reported EPS of -$0.93 for the quarter ended Sep 30, 2026, below the -$0.77 estimate by 20.78%.

    What EPS do analysts expect from MLTX next quarter?

    The consensus EPS estimate for MoonLake Immunotherapeutics for the quarter ending Dec 31, 2026 is -$0.84 from 15 analysts, with estimates from -$0.99 to -$0.69.

    How often does MLTX beat earnings estimates?

    MoonLake Immunotherapeutics beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -7.54%.